Worrawat Engchuan

Worrawat Engchuan

Auto-generated profile, based on publicly available information

Worrawat Engchuan

The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2025 in medRxiv
Verified
Preprint
Open access
PDF file
WEWorrawat Engchuan
Worrawat Engchuan
OSOmar Shanta
Omar Shanta
KKKuldeep Kumar
Kuldeep Kumar
JMJeffrey R. MacDonald
Jeffrey R. MacDonald
BTBhooma Thiruvahindrapuram
Bhooma Thiruvahindrapuram
JSJonathan Sebat
Jonathan Sebat
Psychiatric conditions share common genes, but mechanisms that differentiate diagnoses remain unclear. We present a multidimensional framework for functional analysis of rare copy number variants (CNVs) across 6 diagnostic categories, including schizophrenia (SCZ), autism (ASD), bipolar disorder (BD), depression (MDD), PTSD, and ADHD (N = 574,965). Using gene-set burden analysis (GSBA), we tested duplication (DUP) and deletion (DEL) burden across 2,645 functional gene sets defined by the intersections of pathways, cell types, and cortical regions. While diagnoses converge on shared pathways, mixed-effects modeling revealed divergence of pathway effects by cell type, brain region, and gene dosage. Factor analysis identified latent dimensions aligned with clinical axes. A primary factor (F1) captured reciprocal dose-dependent effects of DUP and DEL in SCZ reflecting positive and negative effects in excitatory versus inhibitory neurons and association versus sensory cortex. SCZ and ASD were both strongly aligned with F1 but with opposing directionalities. Orthogonal factors highlighted neuronal versus non-neuronal effects in mood disorders (F2) and differential spatial distributions of DEL effects in ADHD and MDD (F3). High-impact CNVs at 16p11.2 and 22q11.2 were enriched for combinations of cell-type-specific genes involved in pathways consistent with our broader findings. These results reveal molecular and cellular mechanisms that are broadly shared across psychiatric traits but differ between diagnostic categories in context and directionality.

13 May 2026 in Nature
Verified
Journal Article
Open access
PDF file
CBClarrisa A. Bradley
Clarrisa A. Bradley
SKSangyoon Y. Ko
Sangyoon Y. Ko
MTMeng Tian
Meng Tian
LRLiam T. Ralph
Liam T. Ralph
LDLia D’ABate
Lia D’ABate
SSStephan Scherer
Stephan Scherer
There are around 100 genes or copy-number variations used in genetic testing for autism spectrum disorder (ASD)1,2. The established genes are protein coding, and the associated phenotypes usually extend beyond sociobehavioural traits seen in autism, including cognitive/medical complexities and attention deficit hyperactivity disorder (ADHD)3,4. We examined whole-genome sequencing data in cases of ASD (9,349) and controls (8,332) and identify 27 male individuals with ASD with X-chromosome microdeletions that implicate the long non-coding RNA PTCHD1-AS as an ASD-susceptibility gene (odds ratio = 2.56, P = 0.01). Two Ptchd1-as-knockout mouse models, which were created by disrupting/deleting the evolutionarily conserved exon 3, show ASD-like features in male mice, including increased repetitive behaviours and impaired social behaviour and communication without cognitive comorbidities or ADHD-like behaviours. Hippocampus-dependent synaptic function, complex learning and locomotor activity are unaffected in knockout mice. Native nuclear-enriched mouse Ptchd1-as showed sustained expression from postnatal day 7 onwards in the dorsal striatum, a predominantly GABAergic brain region that is implicated in ASD5. Multi-omics analysis revealed transcriptomic alterations in striatal oligodendrocytes, astrocytes and neurons impacting myelination and synaptic plasticity. Disrupting Ptchd1-as led to reductions in conventional protein kinase C (cPKC) isoforms, altered SRC and GSK-3α/β phosphorylation and enhanced striatal synaptic plasticity (long-term potentiation and long-term depression). Together, these findings implicate striatal molecular and circuit-level dysregulation through PTCHD1-AS in ASD aetiology.

12 February 2026 in medRxiv
Verified
Preprint
Open access
PDF file
MMMarla Mendes
Marla Mendes
WEWorrawat Engchuan
Worrawat Engchuan
STSydney Thompson
Sydney Thompson
XZXiaopu Zhou
Xiaopu Zhou
NSNickie Safarian
Nickie Safarian
EBElemi Breetvelt
Elemi Breetvelt
Low-frequency variants (LFVs), defined by minor allele frequencies (MAF) of 1–5%, occupy the gap between common and rare variants in both frequency and effect size. The conventional genome-wide association study (GWAS) significance threshold (5×10⁻⁸) is overly conservative for LFVs, which account for more than 25% of variants in GWAS. This limitation may obscure meaningful associations in highly heritable yet genetically complex disorders such as autism spectrum disorder (ASD). We hypothesize that the scarcity of significant LFVs in ASD GWAS reflects statistical constraints rather than a true lack of association. To address this, we derived a MAF-specific genome-wide significance threshold using linkage disequilibrium–informed simulations applied to ASD GWAS summary statistics, identifying 2.03×10⁻⁷ as optimal. Applying this threshold revealed three novel LFVs mapping to zinc finger proteins (ZNF420, ZNF781) and known ASD-related genes (KMT2E, PRKDC, MCM4). Enrichment analyses suggested their function in nervous system development and gene regulation. Our findings highlight the contribution of LFVs to ASD risk and underscore the importance of frequency-aware association strategies.

1 January 2015
Verified
Conference Paper
Closed access
TPThiptanawat Phongwattana
Thiptanawat Phongwattana
WEWorrawat Engchuan
Worrawat Engchuan
JCJonathan H. Chan
Jonathan H. Chan
Pathway activity data transformed from gene expression profiles may be used to identify tumors, complex diseases progression, and cellular response to stimuli, and so on. Previous researches utilized data mining techniques on pathway activity data to distinguish subjects or to predict the phenotype outcome of subject directly. However, in the multi-class classification, learning those data mixing with population from different groups may result in contaminated model as excessive information is presented. This research, we use a two-stage approach applying clustering to homogenize training data before building the classification model. Hierarchical Clustering is used as a clustering method and Random Forest is used as classifier for evaluating the performance of the proposed method. The results are promising and show that using a clustering technique before classifying improves classification performance in general.

17 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
GHGuillaume Huguet
Guillaume Huguet
TRThomas Renne
Thomas Renne
CPCécile Poulain
Cécile Poulain
ADAlma Dubuc
Alma Dubuc
KKKuldeep Kumar
Kuldeep Kumar
SJSébastien Jacquemont
Sébastien Jacquemont
Genomic Copy Number Variants (CNVs) that increase risk for neurodevelopmental disorders are also associated with lower cognitive ability in general population cohorts. Studies have focussed on a small set of recurrent CNVs, but burden analyses suggested that the vast majority of CNVs affecting cognitive ability are too rare to reach variant-level association. As a result, the full range of gene-dosage-sensitive biological processes linked to cognitive ability remains unknown. To investigate this issue, we identified all CNVs >50 kilobases in 258k individuals from 6 general population cohorts with assessments of general cognitive abilities. We performed a CNV-GWAS and functional burden analyses, which tested 6502 gene-sets defined by tissue and cell-type transcriptomics as well as gene ontology disrupted by all rare coding CNVs. CNV-GWAS identified a novel duplication at 2q12.3 associated with higher performance in cognitive ability. Among the 864 gene-sets associated with cognitive ability, only 11% showed significant effects for both deletions and duplication. Accordingly, we systematically observed negative correlations between deletion and duplication effect sizes across all levels of biological observations. We quantified the preferential effects of deletions versus duplication using tagDS, a new normalized metric. Cognitive ability was preferentially affected by cortical, presynaptic, and negative-regulation gene-sets when duplicated. In contrast, preferential effects of deletions were observed for subcortical, post-synaptic, and positive-regulation gene-sets. A large proportion of gene-sets assigned to non-brain organs were associated with cognitive ability due to low tissue specificity genes, which were associated with higher sensitive to haploinsufficiency. Overall, most biological functions associated with cognitive ability are divided into those sensitive to either deletion or duplications.

12 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
VFVinicius Furlan
Vinicius Furlan
JMJulian Moran
Julian Moran
NSNelson Bautista Salazar
Nelson Bautista Salazar
OROlivia Rennie
Olivia Rennie
NHNy Hoang
Ny Hoang
SSStephan Scherer
Stephan Scherer
We previously developed the Evaluation of Autism Gene Link Evidence (EAGLE) curation framework and used it to characterise 219 autism-associated genes. However, this took years of human work. We present EAGLE-AI, an automated curation system incorporating large language models (LLMs). On screened paper sets, it achieves F1 91% and scoring error 17.2%, near human performance. EAGLE-AI performs worse on unscreened papers due to table parsing and context overload, which we address using if-else scoring and computer vision tools. Handling of supplementary materials remains an unsolved problem. Our findings demonstrate proof-of-concept for automating most of a clinical genomics curation process.